Global Small Molecule Targeted Cancer Therapy Market Size, Status and Forecast 2021-2027
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecules
1.2.4 Small Molecule Drug Conjugates
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Cancer Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Lymphoma
1.3.3 Melanoma
1.3.4 Multiple Myeloma
1.3.5 Breast Cancer
1.3.6 Prostate Cancer
1.3.7 Other Cancers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Targeted Cancer Therapy Market Perspective (2016-2027)
2.2 Small Molecule Targeted Cancer Therapy Growth Trends by Regions
2.2.1 Small Molecule Targeted Cancer Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Small Molecule Targeted Cancer Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Small Molecule Targeted Cancer Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Small Molecule Targeted Cancer Therapy Industry Dynamic
2.3.1 Small Molecule Targeted Cancer Therapy Market Trends
2.3.2 Small Molecule Targeted Cancer Therapy Market Drivers
2.3.3 Small Molecule Targeted Cancer Therapy Market Challenges
2.3.4 Small Molecule Targeted Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue
3.1.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue (2016-2021)
3.1.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Small Molecule Targeted Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Small Molecule Targeted Cancer Therapy Revenue
3.4 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Cancer Therapy Revenue in 2020
3.5 Small Molecule Targeted Cancer Therapy Key Players Head office and Area Served
3.6 Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
3.7 Date of Enter into Small Molecule Targeted Cancer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Targeted Cancer Therapy Breakdown Data by Type
4.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Type (2016-2021)
4.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2022-2027)
5 Small Molecule Targeted Cancer Therapy Breakdown Data by Application
5.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Application (2016-2021)
5.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Small Molecule Targeted Cancer Therapy Market Size (2016-2027)
6.2 North America Small Molecule Targeted Cancer Therapy Market Size by Type
6.2.1 North America Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2021)
6.2.2 North America Small Molecule Targeted Cancer Therapy Market Size by Type (2022-2027)
6.2.3 North America Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2027)
6.3 North America Small Molecule Targeted Cancer Therapy Market Size by Application
6.3.1 North America Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2021)
6.3.2 North America Small Molecule Targeted Cancer Therapy Market Size by Application (2022-2027)
6.3.3 North America Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2027)
6.4 North America Small Molecule Targeted Cancer Therapy Market Size by Country
6.4.1 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2016-2021)
6.4.2 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Small Molecule Targeted Cancer Therapy Market Size (2016-2027)
7.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Type
7.2.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2021)
7.2.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2022-2027)
7.2.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2027)
7.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Application
7.3.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2021)
7.3.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2022-2027)
7.3.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2027)
7.4 Europe Small Molecule Targeted Cancer Therapy Market Size by Country
7.4.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2016-2021)
7.4.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size (2016-2027)
8.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Type
8.2.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Application
8.3.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region
8.4.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Small Molecule Targeted Cancer Therapy Market Size (2016-2027)
9.2 Latin America Small Molecule Targeted Cancer Therapy Market Size by Type
9.2.1 Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2027)
9.3 Latin America Small Molecule Targeted Cancer Therapy Market Size by Application
9.3.1 Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2027)
9.4 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country
9.4.1 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size (2016-2027)
10.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type
10.2.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application
10.3.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country
10.4.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 OncoGenex Pharmaceuticals, Inc.
11.1.1 OncoGenex Pharmaceuticals, Inc. Company Details
11.1.2 OncoGenex Pharmaceuticals, Inc. Business Overview
11.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Introduction
11.1.4 OncoGenex Pharmaceuticals, Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2016-2021)
11.1.5 OncoGenex Pharmaceuticals, Inc. Recent Development
11.2 Cytokinetics Inc.
11.2.1 Cytokinetics Inc. Company Details
11.2.2 Cytokinetics Inc. Business Overview
11.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Introduction
11.2.4 Cytokinetics Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2016-2021)
11.2.5 Cytokinetics Inc. Recent Development
11.3 Hospira Inc.
11.3.1 Hospira Inc. Company Details
11.3.2 Hospira Inc. Business Overview
11.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Introduction
11.3.4 Hospira Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2016-2021)
11.3.5 Hospira Inc. Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Introduction
11.4.4 GlaxoSmithKline plc Revenue in Small Molecule Targeted Cancer Therapy Business (2016-2021)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Boehringer Ingelheim GmbH
11.5.1 Boehringer Ingelheim GmbH Company Details
11.5.2 Boehringer Ingelheim GmbH Business Overview
11.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Introduction
11.5.4 Boehringer Ingelheim GmbH Revenue in Small Molecule Targeted Cancer Therapy Business (2016-2021)
11.5.5 Boehringer Ingelheim GmbH Recent Development
11.6 Bayer HealthCare AG
11.6.1 Bayer HealthCare AG Company Details
11.6.2 Bayer HealthCare AG Business Overview
11.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Introduction
11.6.4 Bayer HealthCare AG Revenue in Small Molecule Targeted Cancer Therapy Business (2016-2021)
11.6.5 Bayer HealthCare AG Recent Development
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Details
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Introduction
11.7.4 Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2016-2021)
11.7.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Small Molecules
Table 4. Key Players of Small Molecule Drug Conjugates
Table 5. Global Small Molecule Targeted Cancer Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Small Molecule Targeted Cancer Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Small Molecule Targeted Cancer Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Small Molecule Targeted Cancer Therapy Market Share by Regions (2016-2021)
Table 9. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Small Molecule Targeted Cancer Therapy Market Share by Regions (2022-2027)
Table 11. Small Molecule Targeted Cancer Therapy Market Trends
Table 12. Small Molecule Targeted Cancer Therapy Market Drivers
Table 13. Small Molecule Targeted Cancer Therapy Market Challenges
Table 14. Small Molecule Targeted Cancer Therapy Market Restraints
Table 15. Global Small Molecule Targeted Cancer Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Small Molecule Targeted Cancer Therapy Market Share by Players (2016-2021)
Table 17. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2020)
Table 18. Ranking of Global Top Small Molecule Targeted Cancer Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Small Molecule Targeted Cancer Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
Table 22. Date of Enter into Small Molecule Targeted Cancer Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Small Molecule Targeted Cancer Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Small Molecule Targeted Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Small Molecule Targeted Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Small Molecule Targeted Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Small Molecule Targeted Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. OncoGenex Pharmaceuticals, Inc. Company Details
Table 63. OncoGenex Pharmaceuticals, Inc. Business Overview
Table 64. OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Product
Table 65. OncoGenex Pharmaceuticals, Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2016-2021) & (US$ Million)
Table 66. OncoGenex Pharmaceuticals, Inc. Recent Development
Table 67. Cytokinetics Inc. Company Details
Table 68. Cytokinetics Inc. Business Overview
Table 69. Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Product
Table 70. Cytokinetics Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2016-2021) & (US$ Million)
Table 71. Cytokinetics Inc. Recent Development
Table 72. Hospira Inc. Company Details
Table 73. Hospira Inc. Business Overview
Table 74. Hospira Inc. Small Molecule Targeted Cancer Therapy Product
Table 75. Hospira Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2016-2021) & (US$ Million)
Table 76. Hospira Inc. Recent Development
Table 77. GlaxoSmithKline plc Company Details
Table 78. GlaxoSmithKline plc Business Overview
Table 79. GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Product
Table 80. GlaxoSmithKline plc Revenue in Small Molecule Targeted Cancer Therapy Business (2016-2021) & (US$ Million)
Table 81. GlaxoSmithKline plc Recent Development
Table 82. Boehringer Ingelheim GmbH Company Details
Table 83. Boehringer Ingelheim GmbH Business Overview
Table 84. Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Product
Table 85. Boehringer Ingelheim GmbH Revenue in Small Molecule Targeted Cancer Therapy Business (2016-2021) & (US$ Million)
Table 86. Boehringer Ingelheim GmbH Recent Development
Table 87. Bayer HealthCare AG Company Details
Table 88. Bayer HealthCare AG Business Overview
Table 89. Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Product
Table 90. Bayer HealthCare AG Revenue in Small Molecule Targeted Cancer Therapy Business (2016-2021) & (US$ Million)
Table 91. Bayer HealthCare AG Recent Development
Table 92. Abbott Laboratories Company Details
Table 93. Abbott Laboratories Business Overview
Table 94. Abbott Laboratories Small Molecule Targeted Cancer Therapy Product
Table 95. Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2016-2021) & (US$ Million)
Table 96. Abbott Laboratories Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Small Molecule Targeted Cancer Therapy Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Small Molecules Features
Figure 4. Small Molecule Drug Conjugates Features
Figure 5. Global Small Molecule Targeted Cancer Therapy Market Share by Application: 2020 VS 2027
Figure 6. Lymphoma Case Studies
Figure 7. Melanoma Case Studies
Figure 8. Multiple Myeloma Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. Other Cancers Case Studies
Figure 12. Small Molecule Targeted Cancer Therapy Report Years Considered
Figure 13. Global Small Molecule Targeted Cancer Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Small Molecule Targeted Cancer Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Small Molecule Targeted Cancer Therapy Market Share by Regions: 2020 VS 2027
Figure 16. Global Small Molecule Targeted Cancer Therapy Market Share by Regions (2022-2027)
Figure 17. Global Small Molecule Targeted Cancer Therapy Market Share by Players in 2020
Figure 18. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Small Molecule Targeted Cancer Therapy Revenue in 2020
Figure 20. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2016-2021)
Figure 21. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2022-2027)
Figure 22. North America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Small Molecule Targeted Cancer Therapy Market Share by Type (2016-2027)
Figure 24. North America Small Molecule Targeted Cancer Therapy Market Share by Application (2016-2027)
Figure 25. North America Small Molecule Targeted Cancer Therapy Market Share by Country (2016-2027)
Figure 26. United States Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Small Molecule Targeted Cancer Therapy Market Share by Type (2016-2027)
Figure 30. Europe Small Molecule Targeted Cancer Therapy Market Share by Application (2016-2027)
Figure 31. Europe Small Molecule Targeted Cancer Therapy Market Share by Country (2016-2027)
Figure 32. Germany Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Share by Region (2016-2027)
Figure 42. China Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Small Molecule Targeted Cancer Therapy Market Share by Type (2016-2027)
Figure 50. Latin America Small Molecule Targeted Cancer Therapy Market Share by Application (2016-2027)
Figure 51. Latin America Small Molecule Targeted Cancer Therapy Market Share by Country (2016-2027)
Figure 52. Mexico Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Share by Country (2016-2027)
Figure 58. Turkey Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. OncoGenex Pharmaceuticals, Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2016-2021)
Figure 62. Cytokinetics Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2016-2021)
Figure 63. Hospira Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2016-2021)
Figure 64. GlaxoSmithKline plc Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2016-2021)
Figure 65. Boehringer Ingelheim GmbH Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2016-2021)
Figure 66. Bayer HealthCare AG Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2016-2021)
Figure 67. Abbott Laboratories Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed